Certificate number:RU.77.99.88.003.Е.001288.03.17
Date of registration and renewal:17.03.2017
Dosage form: & nbspChewable tablets weighing 425 mg.
Classification "Composition" & nbsp Other dietary supplements
Classification "Clinical" & nbsp BAD-source of monovitamins and vitamin-like substances
Composition: & nbsp

1 tablet contains:

Cholecalciferol (in terms of the vitamin D3) - 10.5 mg (25 μg, equivalent to 1000 IU).

Auxiliary Ingredients: sweetener xylitol (E967), sweetener sorbitol (E420), thickener hydroxypropylcellulose (E463), magnesium fatty acid antigrazing agent, antioxidant alpha-tocopherol (E307), palm oil, modified starch carrier (E1450), sucrose, antioxidant ascorbate sodium (E301), an antiscratching silicon dioxide amorphous (E551), a raspberry flavor, a peach flavor.

Ultra-D Vitamin D3 25 μg (1000 IU) is available in the form of chewable tablets weighing 425 mg.

Scope: & nbsp

Vitamin D3 (or cholecalciferol) is a biologically active substance, a vitamin belonging to the group of fat-soluble. It is proved that vitamin D regulates calcium-phosphorus metabolism, is necessary to enhance the absorption of calcium from the stomach and delivery to various tissues of the body, as well as reabsorption of phosphorus in the renal tubules. Lack of Vitamin in the body D3 is due to inadequate sun exposure or a lack of vitamin A D3 in food. With vitamin deficiency D3 the content of calcium and phosphate in the blood decreases.

Effect of Vitamin D3 on the female reproductive system

Vitamin D3 affects the reproductive processes in women due to the fact that the receptors of this vitamin are in the organs of the female reproductive system [1].

In women with a sufficient level of vitamin D3 in the blood (30 ng / ml and more) the fertilization of eggs occurs more often [2].

Sufficient level of vitamin D3 allows to improve the results of IVF. Most likely, this effect is due to the influence of the vitamin D on the endometrium [3,4].

Taking a Vitamin D3 allows to increase the thickness of the endometrium in women with polycystic ovary syndrome. In addition, in women with polycystic ovary syndrome, vitamin D3 plays an important role in the correction of obesity and the course of the metabolic syndrome [5].

Taking a Vitamin D3 has a positive effect in menstrual cycle disorders [6].

In late reproductive age, the probability of pregnancy in women with high levels of vitamin D3 in the blood above [7].

During menopause in women, the need for a vitamin D3 higher, due to the increased risk of osteoporosis [8].

Studies have shown that taking a mother's vitamin D3 was associated with a lower risk of developing obstructive pulmonary disease in children [9].

Application area:

Ultra-D Vitamin D3 25 μg (1000 IU) is recommended for use:

as a biologically active food additive - an additional source of vitamin D.

Suggested Usage: & nbsp

Adults take 1/2 tablet once a day with meals.

The recommended daily dose (1/2 tablet) contains:

Component

Content in 1/2 tablet

% of

recommended daily intake *

% of recommended daily intake for women **

reproductive

age *,

1st half of pregnancy

2 nd half of pregnancy

nursing

Vitamin D3

12.5 μg (500 ME)

250***

125-250***

100

100

* - ТР TS 022/2011 "Food products in the part of its marking";

** - MR 2.3.1.2432-08. Norms of physiological needs in energy and nutrients for various groups of the population of the Russian Federation. M., 2008;

*** Does not exceed the upper permissible level of consumption, Unified sanitary-epidemiological and hygienic requirements for goods subject to sanitary-epidemiological supervision (control).

Duration of admission: 2 weeks.

Before use, it is recommended to consult a doctor.

Contraindications:

Individual intolerance of components.

Special instructions:

Determination of the daily dose and duration of vitamin intake D3 can be performed by a doctor individually and, depending on the results of laboratory tests, may differ from the recommended dose in this leaflet. Do not exceed the dose recommended by your doctor.

According to the scientific center of endocrinology for correction of deficiency and lack of vitamin D Use cholecalciferol and follow the following guidelines [10]:

Correction of vitamin deficiency D (at the level 25(OH)D less than 20 ng / ml)

Correction of vitamin deficiency D (at the level 25(OH)D 20-29 ng / ml)

Maintaining Vitamin Levels D > 30 ng / ml

- 50,000 IU weekly for 8 weeks inside (or 7,000 IU per day)

- 200,000 IU monthly for 2 months inside (or 7,000 IU per day)

- 150,000 IU monthly for 1.5 months inside (or 5,000 IU per day)

- 7,000 IU per day for 8 weeks inside

- 50,000 IU weekly for 4 weeks inside (or 7,000 IU per day)

- 7,000 IU per day for 4 weeks inside

- 1000 - 2000 IU daily inside

If it is impossible to control the level 25(OH)D during prolonged (> 6 months) treatment it is recommended to adhere to doses not higher than 4 000 IU / day for persons without risk factors for vitamin deficiency D and no more than 10 000 IU / day for people with a risk of vitamin deficiency D [10].

When determining the individual dose of the vitamin D3 it is necessary to take into account its quantity coming from food.

When taking Ultra-D Vitamin D3 25 μg (1000 IU), do not take other vitamin-mineral complexes containing vitamin D3, to avoid hypervitaminosis.

Symptoms of vitamin hypervitaminosis D: elevated blood calcium, nausea, vomiting, headache, muscle pain, palpitations, decreased appetite, thirst, weakness.

The appearance of side effects of the vitamin D3 directly depends on the dose used; side effects are manifested in the case of taking doses much higher than recommended.

If the kidney function is impaired, you should use a vitamin D3 with caution, it is first necessary to consult a doctor. Do not take a vitamin D3 at high levels of calcium or vitamin D3 in blood, urolithiasis or malabsorption syndrome.

Published to date, research data in humans show that the antenatal application of vitamin A D3 (during pregnancy) is safe in doses recommended for pregnant women.

No case of teratogenic action of the vitamin D3 at the person it is not registered.Women planning pregnancy and pregnant women, it is desirable to receive additional vitamin D,, since the entire territory of the Russian Federation is located in a zone endemic for vitamin deficiency D. [10,11,12] Contains a sweetener. When excessive use can have a laxative effect.

Nutritional value of 1 tablet chewing: sugar alcohol - 0.4 g, energy value - 0.9 kcal (4.9 kJ).
Shelf life:

2 years.

Do not use after the expiry date printed on the package.

Storage conditions:Store in the original packaging in a dry place inaccessible to children, at a temperature not exceeding 25 ° C.
Research protocols:In exchange for the certificate of state registration No. RU.77.99.88.003.E.000843.02.16 of 19.02.2016, the expert opinions of the FGBICU "NII Nutrition" No. 72 / E-56 / b-16 of 04/02/2016, FGBUN " FIC Nutrition and Biotechnology "No. 529 / E-1012 / b-16 of December 15, 2016.
Recipient:Orion Pharma, Open CompanyOrion Pharma, Open Company Russia
Information update date: & nbsp07.04.2017
Instructions
Up